FDA approves Roche's oral treatment for advanced breast cancer
The U.S. Food and Drug Administration approved Roche's oral treatment for certain patients with estrogen receptor-positive, HER2-negative advanced breast cancer.
1. FDA approval
The U.S. Food and Drug Administration approved Roche's oral treatment for certain patients with estrogen receptor-positive, HER2-negative advanced breast cancer, the regulator said.





